Interojo Co

Interojo Co Operating Cash Flow

The Operating Cash Flow of Interojo Co (119610.KQ) as of Oct 22, 2026 is 25.34 B KRW. In the previous year, Operating Cash Flow was 19.78 B KRW — a change of 28.09% (higher).

Operating Cash Flow

25.34 BKRW

YoY

28.09%

Last updated:

Operating Cash Flow of Interojo Co is 2025 25.34 B KRW. Operating Cash Flow of Interojo Co was 2024 19.78 B KRW. It decreases by 28.09% higher compared to the previous year.

The Interojo Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
9.19 B KRW
Jan 1, 2019
23.53 B KRW
Jan 1, 2020
17.04 B KRW
Jan 1, 2021
13.83 B KRW
Jan 1, 2022
12.05 B KRW
Jan 1, 2023
8.34 B KRW
Jan 1, 2024
19.78 B KRW
Jan 1, 2025
25.34 B KRW
The Interojo Co Operating Cash Flow history
YEAROperating Cash FlowYoY
25.34 BKRW+28.09%
19.78 BKRW+137.15%
8.34 BKRW-30.76%
12.05 BKRW-12.91%
13.83 BKRW-18.81%
17.04 BKRW-27.58%
23.53 BKRW+155.89%
9.19 BKRW-18.57%
11.29 BKRW-25.36%
15.13 BKRW-11.28%
17.05 BKRW+108.38%
8.18 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Operating Cash Flow of Interojo Co is 25.34 B KRW in 2025.

Operating Cash Flow of Interojo Co changed from 19.78 B KRW to 25.34 B KRW, representing a 28.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Interojo Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Interojo Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Interojo Co

All Key Metrics — Interojo Co